Lv6
1872 积分 2022-04-05 加入
Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infection
20天前
已关闭
Higher level of HBsAg associated with delayed development of HCC in immune-tolerant patients
1个月前
已完结
Management of immune-tolerant chronic hepatitis B
1个月前
已完结
Perspectives on the issues of indeterminate/grey zones of chronic HBV infection
1个月前
已关闭
Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase†
1个月前
已完结
Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
1个月前
已完结
Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
1个月前
已关闭
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
2个月前
已完结
Hepatic Amyloidosis Without Hepatomegaly
5个月前
已完结
Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
5个月前
已完结
皖公网安备34019202002308
